We report on the effect of the calcium channel blocker verapamil administered into the inferior cerebral vein in rats 1 hour after occlusion of the middle cerebral artery. Twenty-four rats were divided into four groups of six rats each. Group A rats received no medication. The other three groups received 0.1 mg verapamil/kg/2 hr. Group B rats received verapamil intravenously. 
R ecent reports suggest that calcium channel blockers may improve ischemic cerebral tissue damage through their vasodilatory effects on cerebral vessels, particularly at the microcirculatory level, and by preventing excessive calcium influx into the cytoplasmic and mitochondrial compartments.
1 -10 However, most experiments have failed to demonstrate improved local cerebral blood flow (LCBF) in focal cerebral ischemic tissue after systemic administration of calcium channel blockers.' '-' 4 Local application of the calcium channel blocker verapamil over the subarachnoid space does, however, produce a significant vasodilatory effect associated with a marked improvement of LCBF in the ischemic cerebral tissue induced by cerebral vasospasm in vivo. 1316 In acute stroke, the systemic and arterial routes often fail to deliver an adequate amount of promising cytoprotective agents because of advanced atherosclerotic processes in the cerebral arterial system or occlusion of the major supplying artery. Since the cerebral venous system has rich microcollateral channels 17 and minimum atherosclerotic changes, 1819 we examined it as a possible therapeutic route for delivering cytoprotective agents into ischemic brain tissue. We recently established that the cerebral venous system of rats with focal cerebral ischemia can tolerate up to 150 mm Hg perfusion pressure without any change of blood-brain barrier (BBB) permeability or LCBF. 20 However, we were unable to significantly improve LCBF by administering autologous arterial blood alone by transvenous perfusion of the brain (TVPOB). 20 We compare the results of TVPOB with verapamil and those achieved through systemic administration of verapamil in the same ischemic rat model. 
Materials and Methods
We used 24 adult male Sprague-Dawley rats weighing 320-400 g. In all rats, cerebral ischemia was produced by occlusion of the left middle cerebral artery (MCA), 21 and 1 hour later TVPOB commenced. The rats were divided into four groups of six rats each. Group A (control) rats underwent surgical preparations for middle cerebral artery occlusion (MCAO) and cannulation into the cerebral vein, but no TVPOB was performed. The other three groups received 0.1 mg verapamil/kg/2 hr: Group B rats received verapamil intravenously, Group C rats received verapamil by TVPOB with autologous blood at 100 mm Hg perfusion pressure, and Group D rats received verapamil by TVPOB with autologous blood at 150 mm Hg perfusion pressure. All six Group A rats, three Group C rats, and three Group D rats were examined by simultaneous quantitative doubletracer autoradiography using 4-[ Details of the surgical preparation, anesthesia, medication, and monitoring of physiologic changes have been published. 20 Briefly, under general anesthesia with 1.5-2.0% halothane, the femoral artery and veins were catheterized and a tracheostomy was performed. A small craniectomy was made at the inferior and posterior part of the squamosa bone. The inferior cerebral vein, anatomically comparable with Labb6's vein in humans, collects venous blood from the centroparietotemporal regions. 17 The midpoint of the main trunk of the inferior cerebral vein was cannulated backwards using a PE-10 polyethylene catheter connected to the conduit system, which consisted of four three-way stopcocks. The distal end of the conduit system was then connected to a polyvinyl chloride bottle of isotonic saline containing 5 units/ml heparin (Organon Canada Ltd., West Hill, Canada). To avoid blocking the catheter and conduit system, <0.1 ml of this heparinized saline was infused intermittently at <30 mm Hg perfusion pressure until the beginning of the autologous blood infusion.
Arterial blood (1 ml) was initially drawn from the femoral artery with a heparinized syringe during 3-4 minutes to avoid any changes in systemic blood pressure. This heparinized arterial blood was then injected into the catheter and the proximal portion of the conduit system through the second three-way stopcock. Autologous arterial blood was infused continuously into the inferior cerebral vein during TVPOB at 0.17 ml/min, 100 mm Hg perfusion pressure and 0.2 ml/min, 150 mm Hg perfusion pressure for Groups C and D, respectively. To replace the blood in the conduit system, the heparinized arterial blood was withdrawn 1 ml at a time at rates similar to those of TVPOB from the femoral artery. The infusion pressure was obtained by compressing the polyvinyl chloride bottle filled with saline using a mercurial sphygmomanometer (Tycos, Taylor Instrument Companies, Asheville, North Carolina) connected at the conduit system's distal end and by gradually increasing the pressure in a stepwise manner from no pressure to the desired pressure. At each step, the pressure rose 20-30 mm Hg; approximately 5 minutes elapsed between steps. During the infusion, the catheter and conduit system were always filled with autologous blood that was replenished periodically according to the infusion schedule described above.
Forty micrograms of verapamil was diluted in 1 ml of 0.9% saline (40 jtg/ml, pH 6.76). This diluted verapamil solution was connected to the conduit system's proximal three-way stopcock and infused at a constant rate of 0.8 /xg/kg/min using a Sage infusion pump (model 355, Orion Research, Inc., Boston, Massachusetts). Therefore, the infusion rate of TVPOB for Group D was 0.2 ml arterial blood+8 fil verapamil/min. The infusion pressure was constantly measured through the conduit system's third three-way stopcock by the transducer mentioned previously. The pressure was maintained within 5 mm Hg using the high-pressure ranges of a blood pressure monitor (Sirecust 322, Siemens Energy and Automation, Cherry Hill, New Jersey) during TVPOB.
The left MCA was occluded proximal to the lateral striate branch, as described by Tamura et al. 21 The general anesthesia was switched to 50 mg/kg i.m. ketamine and 8 mg/kg i.m. xylazine 27 and maintained until the end of the experiment, when the rats were decapitated. The systemic administration of verapamil through the femoral vein (Group B) or by TVPOB (Groups C and D) was started 1 hour after MCAO and ended 2 hours later. Body temperature was kept at approximately 37° C with a heating lamp positioned over the rat. Systemic arterial blood pressure and blood gases were serially checked and maintained within physiologic ranges during the experiment.
A detailed description of the method for measuring LCBF and the local blood-brain transfer constant (/Q using [''FJFAP 22 and ["QAIB, 2 *.* respectively, has been published. 20 Briefly, the autoradiographic method is based on the difference in the physical half-lives of the two tracers The optical density was measured six times in each of three consecutive tissue autoradiograms, and the mean value of the tissue fluorine-18 and carbon- Values are mean+SD; ml/100 g/min. TVPOB, transvenous perfusion of the brain. *tp<0.05, 0.01, respectively, different from control group by two-tailed unpaired / test. 
FIGURE 1. Autoradiograms of[' s F]fluoroantipyrine (or [ l4 C]iodoantipyrine)from coronal section of frontal region (A, D, and G), sensorimotor cortex (B, E, and H), and thalamuslparietal cortex regions (C, F, and I) showing decrease of local cerebral blood flow (LCBF) in left insular and perirhinal cortexes subjacent to operative site in all rats. Group B (intravenous administration of verapamil, D-F) showed no significant changes of LCBF compared with Group A (control, A-C). Group D (transvenous perfusion of the brain with verapamil at 150 mm Hg, G-I) showed extensive increase of LCBF in ipsilateral frontal, sensorimotor, and parietal cortexes.
14 radioactivities was obtained for each locus indicated in the rat brain atlas. 28 The densitometric measurements were made with a Photovolt Densitometer (Model PPD, Densichron, Sargent-Welch, Skokie, Illinois) equipped with a 0.1-mm aperture.
All data are expressed as mean±SD. The statistical analysis of all data was performed using a two-tailed unpaired / test; p<0.05 was considered to indicate significance.
Results
Blood pressure, blood gases, and hematocrit of rats in the four groups did not differ during MCAO regardless of verapamil administration (Table 1) .
LCBF in the four groups are summarized in Table  2 and depicted in Figure 1 . In all rats, LCBF was reduced in the left insular and perirhinal cortexes over the surgical site. Compared with Group A, Group C showed a significant increase of LCBF in the parietal (89%, p<0.01) and sensorimotor cortexes (64%, p<0.05) (Table 2; Figure 1 , A-C; Figure 2) . Group D showed extensive and significant increases of LCBF in the ischemic cortical areas (sensorimotor cortex: 86%,p<0.05; parietal cortex: 100%, p<0.05; auditory cortex: 68%, p<0.05) as well as in the subcortical area (posterolateral portion of the caudoputamen: 57%, p<0.01, Table 2 ; Figure 1 , G-I; Figure 2 ). In Groups C and D, we observed no significant LCBF increases in the regions supplied by the deep branches of the internal carotid artery or by the anterior or posterior cerebral arteries, such as the occipital cortex, hippocampus, amygdala, thalamus, hypothalamus, and dentate (Table 2) . LCBF also did not change significantly in the contralateral nonischemic cerebral regions in Groups C and D. However, Group B showed a slight, nonsignificant, further LCBF reduction in the ischemic cerebral cortex associated with a slight LCBF increase in the contralateral cerebral hemisphere compared with Group A (Table 2 ; Figure 1, D-F; Figure 2 ).
The only increase in /JT, was confined to the small focal area around the left rhinal fissure over the surgical site in Groups A, C, and D due to the surgical artifact. However, there were no changes in K t in the distribution of the occluded MCA, in the ipsilateral normal cortex, or in the contralateral hemisphere. This was also the case in Group B.
Discussion Verapamil, a so-called slow-channel Ca 2+ blocking agent, has a vasodilating effect, particularly on small, resistant vessels. 29 Verapamil is rapidly metabolized in vivo; labeling it with carbon-14 has facili- 
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tated the study of its metabolic decomposition in humans 3031 and animals. 32 The half-life of verapamil in plasma is <20 minutes. Its binding to plasma proteins, approximately 90%, would reduce substantially its pharmacologic activity. 3132 Therefore, verapamil has been considered to be a firstpass metabolic agent, the unique pharmacologic property of which makes it a most suitable drug for TVPOB. In locally perfused tissue, verapamil has minimum systemic side effects. Most investigators 111214 have failed to increase cerebral blood flow after an ischemic insult by the systemic administration of verapamil in spite of long-term continuous infusion. However, local application of verapamil produced vasodilatation in previously constricted artery in vitro 333 and in vivo. 415 - 16 We first confirmed that TVPOB with 0.1 mg verapamil/kg at perfusion pressures of 100 and 150 mm Hg did not alter BBB permeability as measured by quantitative double-tracer autoradiography. We then studied the effects of verapamil administered by TVPOB at perfusion pressures of 100 and 150 mm Hg on LCBF. We compared results of this procedure with results following systemic administration of verapamil in the same ischemic rat model. Intravenous systemic administration of 0.1 mg verapamil/kg/2 hr resulted in a slight further reduction of LCBF in the ischemic cerebral hemisphere, associated with slightly increased LCBF in the nonischemic contralateral cerebral hemisphere compared with the control group ( Table 2) In the nonischemic regions, a relatively low dose of verapamil (0.1 mg/kg/2 hr) did not produce any significant changes in systemic blood pressure or LCBF. Although we administered a relatively low dose of verapamil and autologous arterial blood by TVPOB, a perfusion pressure of 100 mm Hg caused a significant increase of LCBF in the ipsilateral, parietal, and sensorimotor cortexes. Furthermore, the administration of verapamil and autologous arterial blood by TVPOB at a perfusion pressure of 150 mm Hg caused an extensive and significant increase of LCBF not only in the ischemic cortical areas, but also in the subcortical area in the territory of the MCA. LCBF did not change significantly in the nonischemic contralateral cerebral hemisphere.
TVPOB has made it possible to deliver vasoactive and cytoprotective agents more selectively and efficiently into focally ischemic cerebral tissue with minimum systemic side effects. We are investigating this new therapeutic approach for treating acute focal cerebral ischemia further.
